RNA vaccine takes on deadly brain tumors in early trial
NCT ID NCT06389591
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 16 times
Summary
This early-stage study tests a new RNA-based vaccine for adults whose glioblastoma (a fast-growing brain cancer) has come back. The main goals are to see if the vaccine can be made safely and to find the best dose. About 24 participants will receive the vaccine to check for side effects and manufacturing success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.